The majority of children and adolescents with acute myeloid leukemia have detectable anti-DT388-GMCSF IgG concentrations, but at concentrations that should not preclude in vivo activity

Philip D. Hall, Bassem I. Razzouk, Tony E. Willoughby, Thomas W. McLean, Arthur E. Frankel

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'The majority of children and adolescents with acute myeloid leukemia have detectable anti-DT388-GMCSF IgG concentrations, but at concentrations that should not preclude in vivo activity'. Together they form a unique fingerprint.

Medicine & Life Sciences